Sally J. DeNardo - Concepedia

Author

Sally J. DeNardo

Also Known As

DeNardo, Sally J.; Denardo, Gerald L.; Balhorn, Rodney L., S DeNardo, S J DeNardo, S J Denardo, S J. DeNardo, S. Denardo, S. J. DENARDO, S. J. DeNardo, S. J. Denardo, S.J. DENARDO

336

Publications

9.1K

Citations

H-Index

154

Concepts

All Affiliations

University of California, Davis University of California Davis Medical Center Palmetto Hematology Oncology Lawrence Livermore National Laboratory University of California, San Francisco

About

Sally J. DeNardo is an author at University of California, Davis specializing in medicine, immunology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	71	3.2K
2	Health Sciences	21	27	880
3	Engineering	13	15	574
4	Natural Sciences	12	12	933
5	Public Health	1	1	149

Sally J. DeNardo

167

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts. Sally J. DeNardo, Laird Miers, Kathleen R. Lamborn, PubMed Endothelial CellsImmunologyCell DeathCmrit MiceTumor Biology	2002	213
Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy Sally J. DeNardo, Gerald L. DeNardo, Laird Miers, Clinical Cancer Research	2005	197
Copper chelates as probes of biological systems: Stable copper complexes with a macrocyclic bifunctional chelating agent Min K. Moi, Claude F. Meares, Michael J. McCall, Analytical Biochemistry Inorganic ChemistryBiochemistryNatural SciencesCoordination ComplexBioorganometallic Chemistry	1985	193
Application of High Amplitude Alternating Magnetic Fields for Heat Induction of Nanoparticles Localized in Cancer Robert Ivkov, Sally J. DeNardo, Wolfgang Daum, Clinical Cancer Research	2005	185
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma. Gerald L. DeNardo, Sally J. DeNardo, D S Goldstein, Journal of Clinical Oncology	1998	182
Dynamic force spectroscopy of parallel individual Mucin1–antibody bonds Todd Sulchek, Raymond W. Friddle, Kevin C. Langry, Proceedings of the National Academy of Sciences Rupture Force MagnitudeSingle Molecule BiophysicsBinding ForcesNatural SciencesMedicine	2005	173
The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex Min K. Moi, Claude F. Meares, Sally J. DeNardo Journal of the American Chemical Society Peptide WayBioorganic ChemistryAltmetric Attention ScoreComplexmin K. MoiOrganic Chemistry	1988	169
Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. S.V. Deshpande, Sally J. DeNardo, David L. Kukis, PubMed ImmunologyBiological TherapyImmunotherapeuticsImmunotherapyTumor Uptake	1990	150
Left Ventricular Thrombi Identified by Cross-Sectional Echocardiography Anthony N. DeMaria, William J. Bommer, Alexander Neumann, Annals of Internal Medicine Heart FailureApical ThrombiLeft Ventricular ThrombiDiagnosisDiastolic Function	1979	149
Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice. Sally J. DeNardo, Gerald L. DeNardo, Arutselvan Natarajan, PubMed	2007	143

Page 1